• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Neoadjuvant transcatheter arterial chemoembolization and systemic chemotherapy for the treatment of undifferentiated embryonal sarcoma of the liver in children

    2022-12-19 08:06:58MinHeJiaBinCaiCanLaiJunQingMaoJieNiXiongZhongHaiGuanLinJieLiQiangShuMeiDanYingJinHuWang
    World Journal of Clinical Cases 2022年19期
    關(guān)鍵詞:島津離子化質(zhì)譜儀

    Min He, Jia-Bin Cai, Can Lai,Jun-Qing Mao, Jie-Ni Xiong, Zhong-Hai Guan, Lin-Jie Li, Qiang Shu Mei-Dan Ying,Jin-Hu Wang

    Abstract

    Key Words: Undifferentiated embryonal sarcoma of the liver; Unresectable; Neoadjuvant therapy; Transcatheter arterial chemoembolization; Systemic chemotherapy

    lNTRODUCTlON

    Undifferentiated embryonal sarcoma of the liver (UESL) is a rare and aggressive mesenchymal tumor that occurs mainly between the ages of 6 and 10 years, without gender predominance[1]. The prognosis of UESL has previously been considered poor[2]. Modern multimodal treatment and supportive therapy have improved survival[3]. Complete tumor excision plays the central role in the treatment of UESL[4]. Transcatheter arterial chemoembolization (TACE) is an effective therapeutic method and has been widely used in the treatment of patients with hepatic malignancy[5,6]. In an attempt to increase resection rate and improve the outcome of UESL, we performed preoperative TACE combined with systematic chemotherapy for the treatment of unresectable UESL in children and evaluated its feasibility and effectiveness.

    MATERlALS AND METHODS

    Patient characteristics

    All the procedures in this study conformed to the ethical requirements of the Ethics Committee of the Children’s Hospital, Zhejiang University School of Medicine and have been approved. The children’s families provided signed informed consent. Six patients with UESL received neoadjuvant therapy (NAT) at our hospital between January 2004 and December 2019. The patients were 4 boys and 2 girls with a mean age of 7 years (range, 3-11 years). The symptoms at admission included abdominal pain, abdominal mass and jaundice. The longest tumor ranged from 8.6 to 14.8 cm (mean, 12 cm). One patient presented with pulmonary metastasis and another with retroperitoneal lymph node metastases. The details of the six patients are summarized in Table 1.

    NAT

    Pathological diagnosis was obtained by percutaneous needle biopsy before treatment in all patients. NAT included preoperative TACE and systemic chemotherapy. TACE was performed under general and sacral block anesthesia. With continuous monitoring, including electrocardiography, blood pressure and oxygen saturation measurements, the femoral artery was catheterized using the Seldinger technique. A 5-F Pigtail catheter was introduced into the abdominal aorta to perform aortography and define the main feeding artery of the tumor, and then a 4-F or 5-F Cobra catheter was advanced toward the tumor-feeding arteries for chemoembolization. The chemoembolic emulsion consisted of pirarubicin 40 mg/m2, vindesine 3 mg/m2, cisplatin 90 mg/m2and iodized oil 0.5 mLpermaximum tumor diameter (cm), which has been proved to have good efficacy and safety in the treatment of UESL and other tumors in our center[5,7]. The drugs were mixed and diluted in 120-180 mL of normal saline, and infused into the feeding artery at a rate of 120 mL/h. After perfusion, the outline of the entire tumor was revealed (Figure 1).

    Intravenous chemotherapy was administered 3 wk after TACE if the blood parameters were at normal levels. The chemotherapy regimen consisted of vindesine 3 mg/m2on day 1, carboplatin 150 mg/m2and pirarubicin 20 mg/m2on days 2 and 3. Vindesine was injected every 7 d.

    Tumor response was evaluated by enhanced computed tomography (CT) scan or magnetic resonance imaging after every cycle of NAT according to the revised Response Evaluation Criteria In Solid Tumors (RECIST) version 1.1[8]. Surgical resection was carried out after one or two cycles depending on the patient’s response. Postoperative intravenous chemotherapy was given every 3 wk, and the drugs administered were those listed above.

    Toxicity evaluation

    Toxicity was evaluated after each session of NAT. Cardiac function was monitored by echocardiography and ECG; renal function by serum electrolytes, urea, creatinine, and creatinine clearance; and liver function by aspartate aminotransferase and alanine aminotransferase (ALT). Complete blood cell count was repeated weekly to assess bone marrow suppression.

    Follow-up

    All patients were followed every 2 mo during the first year after comprehensive treatment, every 3 mo during the second and third years, every 6 mo during the fourth and fifth years and annually after 5 years. Follow-up examinations included physical check-up, imaging (abdominal ultrasound and CT, chest X-ray or CT), and laboratory testing (blood and urine analysis, and liver and renal function tests).

    RESULTS

    TACE was successfully performed in all patients. The tumor volumes decreased by 18.2%-68.7%, with a mean decrease of 36% after 1 cycle of NAT (t= 3.524,P= 0.017). According to the RECIST criteria, 4 patients had a partial response (PR) and underwent surgery, while 2 had stable disease (SD) and received another cycle of NAT before surgery. Retroperitoneal lymph node metastasis and pulmonary metastasis observed in one patient, respectively, were slightly reduced after TACE, and no regrow or other lesions appeared before surgery. Total tumor resection was performed in all patients without positive surgical margins and major postoperative complications. Retroperitoneal lymph node dissection was performed in the patient with lymph node metastasis. The patient with lung metastasis was not treated surgically as the lesions were no longer obvious after chemotherapy. Massive tumor necrosis was seen on pathological examination of the surgical specimen: > 90% necrosis in 2, > 50% necrosis in 3, and 25% necrosis in 1, with an average of 71.8%. Six to 10 courses of regular venous chemotherapy were administered after surgery in patients without metastasis, and 12 courses in the 2 patients with metastases.

    The toxic side effects included fever (37.8-39.9 °C) in 5 cases, nausea and vomiting in 3, and mild bone marrow suppression in 3, all these symptoms recovered within 1-2 wk following symptomatic treatment. All patients showed varying degrees of ALT elevation, which returned to normal within 7-10 d after treatment with hepatoprotective drugs. No cardiac or renal toxicity, bleeding or nontarget embolization occurred.

    Table 1 Clinicpathological data, treatment, follow-up and outcome of 6 patients with undifferentiated embryonal sarcoma of the liver

    Figure 1 Transcatheter arterial chemoembolization procedure of case 6. A: The catheter was introduced into the tumor-feeding artery and performed angiography, showing the stereoscopic configuration of "holding ball"; B: After injection of anticarcinogen and lipiodol, the outline of the entire tumor was revealed.

    The follow-up duration ranged from 2 to 15 years (median 8 years), and the follow-up rate was 100%. At the last follow-up on February 1, 2021, all patients were alive and disease-free.

    DlSCUSSlON

    Early detection of UESL is difficult, and it is usually found when the tumor becomes larger or metastasizes. It metastasizes in up to 15% of children, usually to the lungs, pleura and peritoneum[9]. Preoperative chemotherapy is currently recommended if a huge unresectable tumor or metastases are present. Although intravenous chemotherapy, as the mainstay of adjuvant treatment for UESL, has improved survival rates, the toxicity induced by systemic chemotherapy may result in early death or potential long-term and late effects[10,11]. In addition, the therapeutic effects in UESL with incomplete resection or distant metastases are still unsatisfactory[12].

    TACE was first introduced in the treatment of adult liver tumor in the late 1970s and yielded good results[13]. Since then, reports of TACE in pediatric cases of hepatoblastoma have gradually increased[6,14,15]. In previous studies at our center, preoperative TACE was effective in the treatment of UESL in two cases[5]. Also, neoadjuvant TACE and systemic chemotherapy have been administered in patients with Wilms tumor and clear cell sarcoma of the kidney and achieved satisfactory results[7,16].

    Complete tumor excision plays a central role in the treatment of UESL[4]. TACE can increase the total resection rate in several ways. TACE can deliver a higher concentration of anticancer drugs into the tumorviadirect perfusion through the tumor-feeding artery, which reduces the dose of drugs and systemic toxicity[5,6,16]. Lipiodol embolization can reduce the blood supply of tumor and accelerate necrosis. High concentrations of chemotherapeutic drugs and internal ischemia cause the tumor to gradually shrink. After TACE, a pseudo-capsule can be seen around the tumor and a boundary exists between the tumor and normal liver tissue during the operation (Figure 2). These are conducive to complete resection, reducing the rate of positive surgical margins, and diminishing intraoperative bleeding (Figure 3). In this study, all the patients achieved total resection without positive surgical margins and severe bleeding.

    TACE plays an important role in the primary lesion but has little effect on distal metastasis[15,17]. In this series, two patients had pulmonary and retroperitoneal lymph node metastasis on admission, respectively. Fortunately, after TACE and before systemic chemotherapy, we found that the metastasis was slightly reduced and no other lesions appeared. Following infusion into the hepatic artery, chemotherapy drugs will still flow through the hepatic vein to the heart and the entire body; thus, the extrahepatic lesions can also be suppressed. However, intravenous chemotherapy is still essential, as the dose of chemotherapy drugs flowing into the body following TACE is limited, and do not achieve an effective concentration. Preoperative intravenous chemotherapy can effectively inhibit primary hepatic and extrahepatic lesions, while postoperative intravenous chemotherapy can reduce the risk of recurrence and improve the survival rate[18,19]. Therefore, systemic chemotherapy can complement TACE. In our series, prolonged postoperative chemotherapy was performed in the two patients who are presently recurrence-free. However, the prognosis is poor, even if the patient receives intravenous chemotherapy, when complete excision of the tumor cannot be achieved[4]. The patient with lung metastases who is currently event-free still requires long-term follow-up.

    In recent years drug-eluting beads (DEBs) have been introduced as novel drug-delivery agents for TACE, which can deliver higher concentrations of drugs to the tumor and lower systemic concentrations[20]. Studies have shown a lower incidence of systemic toxicity and improved tolerance with DEBTACE, but overall survival did not differ from conventional lipiodol-TACE[21,22]. DEB-TACE has been widely used for the treatment of hepatocellular carcinoma in adults, but has not been reported in pediatric liver malignancies, and its clinical safety needs to be confirmed by further clinical trials in children. In addition, DEB-TACE reduces systemic complications by lowering extrahepatic drug concentrations, but it also decreases the inhibition of extrahepatic lesions. Therefore, DEB-TACE was not used in this study. In the near future, DEB-TACE is expected to be applied in the treatment of unresectable intrahepatic malignancy in pediatric patients.

    No technical complications including bleeding, vascular injury, or nontarget embolization were noted in this study. Nontarget embolization must be viewed as a critical situation during the TACE procedure, as its appearance may lead to serious consequences[23]. The incidence of nontargeted organ embolization, such as pulmonary embolism, splenic infarction, and gallbladder infarction, was found to be approximately 5%[23,24]. The main risk factors for the development of these complications include: (1) Non-selective placement of the catheter; (2) High doses of cytostatics and iodized oil used in TACE; and (3) Use of small-diameter embolic agents[24]. A case of paraplegia after TACE in a patient with clear cell sarcoma of the kidney was reported in our center, which was caused by injection of chemotherapeutic drugs and lipiodol into the spinal cord through the lumbar artery. Hence, angiography must be performed repeatedly to confirm the location of the catheter during the TACE procedure especially before injection of the embolic agent.

    Postembolization syndrome and drug toxicity mainly include fever, abdominal pain, gastrointestinal reaction (nausea and vomiting), myelosuppression and organ damage (cardiotoxicity, renal insufficiency, and hepatic dysfunction)[25]. In our cases, fever was the most common symptom after TACE, possibly due to massive necrosis of the large tumor, which lasted a long time and did not respond to antibiotics. Under such circumstances, short-term small doses of hormones can be used to suppress inflammation and lower prolonged fever. Elevated ALT levels occurred in all of our patients, which returned to normal within 7-10 d after treatment without affecting follow-up treatment. Renal failure, cardiac damage, and severe myelosuppression did not occur. Hence, NAT may be considered a safe preoperative treatment for UESL.

    Figure 2 The imaging manifestation of case 6. A and B: Computed tomography scans showed a giant mass of the right liver (diameter 14.8 cm); C and D: One month after neoadjuvant therapy: The tumor volumes shrunk by 48.8%, lipiodol deposits in the tumor with a clear boundary; E and F: One month after tumor resection.

    Figure 3 These are conducive to complete resection, reducing the rate of positive surgical margins, and diminishing intraoperative bleeding. A: The gross of tumor appears as border clear with about 10 cm in diameter; B: The cut surface is red, brown or yellow and has soft qualitative with focal necrosis.

    It is noteworthy that two of our patients underwent 2 cycles of NAT before surgery. They achieved SD (tumor shrinkage was approximately 20%) after one cycle of NAT, and still had large tumors with PRETEXT stage III on radiography[26]. After another cycle of NAT, PRs (tumor shrinkage of approximately 35%) were achieved. Therefore, it is suggested that patients who are insensitive to the initial response should be considered for a second round of NAT, which can yield better results. However, unlimited chemotherapy is not desirable. Generally, surgery should be performed after two cycles of NAT, and liver transplantation should be considered if a limited response occurs in a patient with an unresectable tumor.

    There were some limitations in this study. Firstly, the data were from a single institution and based on a retrospective analysis. In addition, there was no control group due to the small number of cases, and the assessment of disease response cannot definitely be attributed to TACE or systemic chemotherapy. Further prospective and controlled studies with a larger cohort are needed to compare the efficacy of TACE, systemic chemotherapy and NAT for UESL, respectively.

    CONCLUSlON

    The present study indicated that the use of NAT effectively reduced tumor volume, cleared tumor margins, and caused massive tumor necrosis. This chemotherapy regimen may be a promising choice for successful surgery of UESL in children.

    ARTlCLE HlGHLlGHTS

    FOOTNOTES

    Author contributions:All authors contributed equally to this work; Wang JH was the guarantor and designed the study; He M drafted the initial manuscript; Wang JH and Ying MD helped to review the literature; Lai C and Wang JH conducted the TACE process; Mao JQ and Li LJ were the oncologists who treated the patient; Wang JH, He M, Cai JB, Xiong JN, Guan ZH and Shu Q were the surgeons who treated the patient; all authors issued final approval for the version to submitted.

    Supported byYouth Program of Natural Science Foundation of Zhejiang Province, No. LQ20H160027; and National Natural Science Foundation of China, No. U20A20137.

    lnstitutional review board statement:The study was reviewed and approved by the Children’s Hospital, Zhejiang University School of Medicine Institutional Review Board, No. 2021-IRB-252.

    lnformed consent statement:All study participants, or their legal guardian, provided informed written consent prior to study enrollment.

    美國Waters公司MICROMASS Quattro Micro API型質(zhì)譜儀,配有電噴霧離子化源(ESI),數(shù)據(jù)采集:MassLynx 4.1軟件(美國Waters公司)。島津LC‐20 10CHT高效液相色譜儀,恒溫水浴箱(Heto Holten Denmark),匹配紫外檢測器、熒光檢測器。

    Conflict-of-interest statement:All the authors report no relevant conflicts of interest for this article.

    Data sharing statement:No additional data are available.

    Open-Access:This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BYNC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is noncommercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

    Country/Territory of origin:China

    ORClD number:Min He 0000-0003-0178-097X; Jia-Bin Cai 0000-0002-2233-0022; Can Lai 0000-0002-4474-3987; Jun-Qing Mao 0000-0002-3162-9106; Jie-Ni Xiong 0000-0003-1603-1728; Zhong-Hai Guan 0000-0002-8397-4585; Lin-Jie Li 0000-0001-7311-7283; Qiang Shu 0000-0002-4106-6255; Mei-Dan Ying 0000-0003-0039-9683; Jin-Hu Wang 0000-0002-7749-2475.

    S-Editor:Fan JR

    L-Editor:A

    P-Editor:Fan JR

    猜你喜歡
    島津離子化質(zhì)譜儀
    Impaired eye tracking is associated with symptom severity but not dynamic postural control in adolescents following concussion
    單細(xì)胞質(zhì)譜分析方法研究進(jìn)展
    廣告索引
    水利信息化(2020年1期)2020-01-04 07:07:11
    使用尖玻片、毛細(xì)管和尖滴管三種玻璃尖端電噴霧離子化質(zhì)譜分析方法
    納米金輔助介質(zhì)阻擋放電離子化質(zhì)譜分析法在獸藥飼料快檢中的應(yīng)用
    讓科技還原真實,以熱情回報社會—訪島津企業(yè)管理(中國)有限公司市場部部長胡家祥
    構(gòu)建模型,解決質(zhì)譜儀問題
    基于質(zhì)譜儀爐氣分析的VOD精煉過程模型開發(fā)
    上海金屬(2015年3期)2015-11-29 01:10:04
    熱電離飛行時間質(zhì)譜儀性能評價
    氦離子化檢測器氣相色譜法分析氦中微量氖①
    低溫與特氣(2012年4期)2012-01-10 01:52:58
    亚洲最大成人av| 久久久久九九精品影院| 国产伦精品一区二区三区视频9| 国产女主播在线喷水免费视频网站 | 欧美日本亚洲视频在线播放| 成年女人看的毛片在线观看| 91精品一卡2卡3卡4卡| 色尼玛亚洲综合影院| 狂野欧美白嫩少妇大欣赏| 国产精品嫩草影院av在线观看| 一个人观看的视频www高清免费观看| 一级毛片电影观看 | a级一级毛片免费在线观看| 欧美丝袜亚洲另类| 国产精品久久视频播放| 我要搜黄色片| 久久久久久久午夜电影| 久久人人爽人人爽人人片va| 美女黄网站色视频| 精品午夜福利在线看| 日韩欧美三级三区| 色吧在线观看| 亚洲精品色激情综合| 99久久精品热视频| 男人舔女人下体高潮全视频| 爱豆传媒免费全集在线观看| 日日撸夜夜添| 中文欧美无线码| 亚洲精品久久久久久婷婷小说 | 久久久久久久久久久丰满| 高清毛片免费看| 极品教师在线视频| 干丝袜人妻中文字幕| 美女 人体艺术 gogo| 在线免费十八禁| 国产精品嫩草影院av在线观看| 麻豆国产av国片精品| 久久午夜亚洲精品久久| 美女cb高潮喷水在线观看| 18禁裸乳无遮挡免费网站照片| 99国产精品一区二区蜜桃av| 亚洲五月天丁香| 天天躁日日操中文字幕| 亚洲精品久久国产高清桃花| 高清毛片免费观看视频网站| 菩萨蛮人人尽说江南好唐韦庄 | 三级毛片av免费| 国产精品嫩草影院av在线观看| 国产精品一区www在线观看| 狂野欧美白嫩少妇大欣赏| 天天躁日日操中文字幕| 国产黄片视频在线免费观看| 欧美一区二区亚洲| 卡戴珊不雅视频在线播放| 欧美xxxx黑人xx丫x性爽| 欧美成人一区二区免费高清观看| 国产精华一区二区三区| 日韩亚洲欧美综合| 午夜免费激情av| 性插视频无遮挡在线免费观看| 亚洲婷婷狠狠爱综合网| 欧美成人a在线观看| 国产成人a∨麻豆精品| 给我免费播放毛片高清在线观看| av视频在线观看入口| 噜噜噜噜噜久久久久久91| 亚洲18禁久久av| 变态另类丝袜制服| 欧美日韩乱码在线| 搡老妇女老女人老熟妇| 91久久精品国产一区二区成人| 国产成人a∨麻豆精品| 麻豆国产av国片精品| 亚洲一区高清亚洲精品| 国产单亲对白刺激| 亚洲av电影不卡..在线观看| 乱码一卡2卡4卡精品| 高清在线视频一区二区三区 | 波多野结衣高清无吗| 日本与韩国留学比较| 日韩制服骚丝袜av| 国产精品,欧美在线| 成年女人永久免费观看视频| 综合色av麻豆| 夜夜爽天天搞| 一本久久精品| 高清毛片免费观看视频网站| 国产精品久久久久久精品电影小说 | 五月玫瑰六月丁香| 国产成人福利小说| 国产一区亚洲一区在线观看| 热99在线观看视频| 日韩三级伦理在线观看| 精品午夜福利在线看| 久久人人爽人人爽人人片va| 一级二级三级毛片免费看| 亚洲av熟女| 天天躁日日操中文字幕| 美女cb高潮喷水在线观看| 国产麻豆成人av免费视频| 晚上一个人看的免费电影| 亚洲国产精品国产精品| 啦啦啦韩国在线观看视频| 青春草视频在线免费观看| 成人综合一区亚洲| 成人美女网站在线观看视频| 国产探花在线观看一区二区| 国产午夜精品一二区理论片| 91狼人影院| 色综合色国产| 麻豆久久精品国产亚洲av| 午夜福利高清视频| 精品国产三级普通话版| 色哟哟·www| 成人漫画全彩无遮挡| 国产精品久久久久久av不卡| 精品欧美国产一区二区三| 国产麻豆成人av免费视频| 国产精品久久电影中文字幕| 亚洲图色成人| 午夜精品一区二区三区免费看| 啦啦啦观看免费观看视频高清| 国产伦精品一区二区三区四那| 特级一级黄色大片| 婷婷精品国产亚洲av| 国产精品综合久久久久久久免费| 久久99精品国语久久久| 精华霜和精华液先用哪个| 国产精品人妻久久久影院| 一级毛片电影观看 | 日日啪夜夜撸| 国产 一区精品| 久久久久久伊人网av| 亚洲国产欧洲综合997久久,| 狂野欧美激情性xxxx在线观看| 午夜亚洲福利在线播放| 少妇猛男粗大的猛烈进出视频 | 美女 人体艺术 gogo| a级毛色黄片| 免费看a级黄色片| 成人三级黄色视频| 高清日韩中文字幕在线| 亚洲熟妇中文字幕五十中出| 亚洲av成人av| 日本av手机在线免费观看| 午夜精品在线福利| 女的被弄到高潮叫床怎么办| 国产 一区 欧美 日韩| 日韩在线高清观看一区二区三区| 色综合色国产| 91久久精品电影网| 97人妻精品一区二区三区麻豆| 久久精品国产自在天天线| 国产亚洲91精品色在线| 激情 狠狠 欧美| 高清毛片免费观看视频网站| 久久久久性生活片| 亚洲av电影不卡..在线观看| 久久人妻av系列| 99精品在免费线老司机午夜| 中文资源天堂在线| 欧美日韩综合久久久久久| 1000部很黄的大片| 2021天堂中文幕一二区在线观| 成人国产麻豆网| 又粗又硬又长又爽又黄的视频 | 久99久视频精品免费| 国产精品一二三区在线看| 欧美高清性xxxxhd video| 欧美变态另类bdsm刘玥| 免费av不卡在线播放| 日韩av不卡免费在线播放| 菩萨蛮人人尽说江南好唐韦庄 | 黄色日韩在线| 国产女主播在线喷水免费视频网站 | 久久人人精品亚洲av| 哪个播放器可以免费观看大片| 亚洲精品色激情综合| 亚洲七黄色美女视频| 精品人妻熟女av久视频| 午夜福利成人在线免费观看| 中文字幕久久专区| 久久鲁丝午夜福利片| 亚洲电影在线观看av| 91aial.com中文字幕在线观看| 国产成年人精品一区二区| 色综合站精品国产| 免费观看的影片在线观看| 欧美3d第一页| 亚洲国产精品国产精品| 91精品一卡2卡3卡4卡| 免费av不卡在线播放| 久久热精品热| 亚洲美女视频黄频| 亚洲最大成人av| 成人午夜高清在线视频| 美女内射精品一级片tv| 乱系列少妇在线播放| 国产av一区在线观看免费| 成人午夜精彩视频在线观看| 一个人看的www免费观看视频| av天堂在线播放| 我的女老师完整版在线观看| 国产精品女同一区二区软件| 日韩亚洲欧美综合| 一卡2卡三卡四卡精品乱码亚洲| 高清在线视频一区二区三区 | or卡值多少钱| 亚洲欧美中文字幕日韩二区| 高清毛片免费看| 免费无遮挡裸体视频| 国产亚洲5aaaaa淫片| 亚洲精品色激情综合| 综合色av麻豆| 麻豆成人午夜福利视频| 亚洲av不卡在线观看| 成人一区二区视频在线观看| 中文亚洲av片在线观看爽| av天堂在线播放| 免费电影在线观看免费观看| 国产一区二区亚洲精品在线观看| 男人和女人高潮做爰伦理| 欧美高清性xxxxhd video| 久久久久久久久中文| 一区二区三区高清视频在线| 99热网站在线观看| 青青草视频在线视频观看| 欧美色视频一区免费| 观看免费一级毛片| 亚洲国产精品合色在线| 久久久久久九九精品二区国产| 亚州av有码| a级毛片a级免费在线| 亚洲成人久久爱视频| 国产精品电影一区二区三区| 久久精品91蜜桃| 国内揄拍国产精品人妻在线| 午夜老司机福利剧场| 国产久久久一区二区三区| 天天一区二区日本电影三级| 国产一区二区三区av在线 | 免费人成在线观看视频色| 麻豆成人av视频| 日韩av不卡免费在线播放| 国产精品,欧美在线| 亚洲精品影视一区二区三区av| 给我免费播放毛片高清在线观看| 晚上一个人看的免费电影| 真实男女啪啪啪动态图| 成人永久免费在线观看视频| 啦啦啦韩国在线观看视频| 午夜免费男女啪啪视频观看| 国产探花在线观看一区二区| av天堂中文字幕网| avwww免费| 69人妻影院| 特大巨黑吊av在线直播| 亚洲精华国产精华液的使用体验 | 久久韩国三级中文字幕| 91精品国产九色| 成人永久免费在线观看视频| 日本免费一区二区三区高清不卡| 在线免费观看的www视频| 亚洲精品影视一区二区三区av| 人妻久久中文字幕网| 日本熟妇午夜| 亚洲国产精品sss在线观看| 亚洲最大成人av| 久久精品国产亚洲网站| 免费一级毛片在线播放高清视频| 亚洲中文字幕日韩| 久久精品夜夜夜夜夜久久蜜豆| 观看美女的网站| 51国产日韩欧美| 国产精品野战在线观看| 高清午夜精品一区二区三区 | 日韩欧美国产在线观看| 伊人久久精品亚洲午夜| 久久欧美精品欧美久久欧美| 成年女人永久免费观看视频| 午夜激情欧美在线| 国产伦精品一区二区三区四那| 久久久久久九九精品二区国产| 床上黄色一级片| 1024手机看黄色片| 中文在线观看免费www的网站| 网址你懂的国产日韩在线| 在线观看一区二区三区| а√天堂www在线а√下载| 99久国产av精品国产电影| 欧美高清性xxxxhd video| 日韩国内少妇激情av| 久久99精品国语久久久| 综合色av麻豆| 欧美色欧美亚洲另类二区| 在线播放无遮挡| 国产三级在线视频| 久久久精品欧美日韩精品| 久久精品国产亚洲网站| 成人综合一区亚洲| 边亲边吃奶的免费视频| 国产成人福利小说| 51国产日韩欧美| 亚洲精华国产精华液的使用体验 | 国产淫片久久久久久久久| 国产高清三级在线| 身体一侧抽搐| 高清日韩中文字幕在线| 久久久久九九精品影院| 尤物成人国产欧美一区二区三区| 欧美日韩一区二区视频在线观看视频在线 | 最近最新中文字幕大全电影3| 欧美区成人在线视频| 免费不卡的大黄色大毛片视频在线观看 | 久久久a久久爽久久v久久| 夜夜看夜夜爽夜夜摸| 国产亚洲91精品色在线| 51国产日韩欧美| 久久久久免费精品人妻一区二区| 国产 一区精品| 久久6这里有精品| 内地一区二区视频在线| 小说图片视频综合网站| 国产高清视频在线观看网站| 久久久久网色| 91精品一卡2卡3卡4卡| 久久国产乱子免费精品| 欧美激情在线99| 国产 一区 欧美 日韩| 一进一出抽搐gif免费好疼| 国产男人的电影天堂91| 能在线免费观看的黄片| 亚洲人成网站在线观看播放| 蜜臀久久99精品久久宅男| 成人漫画全彩无遮挡| 99久国产av精品| 一个人看的www免费观看视频| 国产精品国产三级国产av玫瑰| 男人的好看免费观看在线视频| 久久久国产成人精品二区| 中文字幕人妻熟人妻熟丝袜美| 久久99热6这里只有精品| 精品久久久久久久久久免费视频| 国产精品一区二区在线观看99 | 精品欧美国产一区二区三| 久久久久久久久久成人| 欧美又色又爽又黄视频| 欧美性感艳星| 亚洲精品456在线播放app| 婷婷精品国产亚洲av| av又黄又爽大尺度在线免费看 | 丰满乱子伦码专区| 男人狂女人下面高潮的视频| 国产精品一区二区在线观看99 | 韩国av在线不卡| 国产精品国产高清国产av| 高清日韩中文字幕在线| 成人av在线播放网站| 日韩欧美在线乱码| 人人妻人人澡欧美一区二区| 日本av手机在线免费观看| 亚洲美女搞黄在线观看| 亚洲欧美精品自产自拍| 亚洲欧洲日产国产| av天堂在线播放| 搡老妇女老女人老熟妇| 直男gayav资源| 色哟哟哟哟哟哟| a级毛片a级免费在线| 国产精品久久久久久久久免| 在线观看免费视频日本深夜| 国产精品免费一区二区三区在线| 乱系列少妇在线播放| 久久久久久久久久成人| 欧美bdsm另类| 18禁裸乳无遮挡免费网站照片| 99精品在免费线老司机午夜| 国产三级中文精品| 日本av手机在线免费观看| 乱码一卡2卡4卡精品| 精品人妻偷拍中文字幕| 搡老妇女老女人老熟妇| 精品久久久久久成人av| 国产精品综合久久久久久久免费| 青青草视频在线视频观看| 级片在线观看| 精品一区二区三区人妻视频| 一级二级三级毛片免费看| 一卡2卡三卡四卡精品乱码亚洲| 全区人妻精品视频| 成人漫画全彩无遮挡| 99热6这里只有精品| 看十八女毛片水多多多| 久久人人爽人人爽人人片va| 干丝袜人妻中文字幕| 欧美日韩综合久久久久久| 丰满乱子伦码专区| 老司机福利观看| 亚洲成人久久性| 观看美女的网站| 国产av一区在线观看免费| 欧美一区二区精品小视频在线| 少妇裸体淫交视频免费看高清| 色尼玛亚洲综合影院| 91久久精品电影网| av在线播放精品| 日韩大尺度精品在线看网址| 国产午夜精品久久久久久一区二区三区| 岛国在线免费视频观看| 亚洲人成网站高清观看| 99国产极品粉嫩在线观看| 国产精品久久久久久av不卡| 精品国内亚洲2022精品成人| 亚洲成人中文字幕在线播放| 亚洲欧美日韩高清专用| 不卡视频在线观看欧美| 99在线人妻在线中文字幕| 欧美成人免费av一区二区三区| 边亲边吃奶的免费视频| 亚洲七黄色美女视频| 国产激情偷乱视频一区二区| 精品国产三级普通话版| 精品无人区乱码1区二区| 在线a可以看的网站| 国产精品精品国产色婷婷| 高清在线视频一区二区三区 | 日韩国内少妇激情av| 波多野结衣高清作品| 一级av片app| 插逼视频在线观看| 欧美性猛交╳xxx乱大交人| 色尼玛亚洲综合影院| 亚洲av中文av极速乱| 亚洲国产精品成人综合色| 又黄又爽又刺激的免费视频.| 国产真实伦视频高清在线观看| 亚洲国产色片| 少妇熟女aⅴ在线视频| 中文精品一卡2卡3卡4更新| 国产v大片淫在线免费观看| 身体一侧抽搐| 少妇猛男粗大的猛烈进出视频 | 内射极品少妇av片p| 国产成年人精品一区二区| 亚洲欧美精品综合久久99| ponron亚洲| 亚洲五月天丁香| 色5月婷婷丁香| 国产国拍精品亚洲av在线观看| 国产精品蜜桃在线观看 | 爱豆传媒免费全集在线观看| 国产成人a∨麻豆精品| 插阴视频在线观看视频| 91狼人影院| 哪里可以看免费的av片| 日本在线视频免费播放| 国产三级在线视频| 久久久国产成人免费| 成人亚洲欧美一区二区av| 欧美性猛交╳xxx乱大交人| 免费一级毛片在线播放高清视频| 久久精品国产清高在天天线| 亚洲精品久久国产高清桃花| 久久久久久久久久成人| 精品久久久久久久久av| 精品99又大又爽又粗少妇毛片| 国产三级在线视频| 麻豆成人午夜福利视频| av天堂中文字幕网| 久久综合国产亚洲精品| 日韩视频在线欧美| 国产伦精品一区二区三区视频9| 国产69精品久久久久777片| 成人毛片60女人毛片免费| 男女视频在线观看网站免费| 97超碰精品成人国产| 99在线人妻在线中文字幕| 高清毛片免费看| 中文欧美无线码| 乱系列少妇在线播放| 国产精品久久久久久久电影| 深爱激情五月婷婷| 可以在线观看毛片的网站| 久久久久久久久久黄片| 99久久人妻综合| 久久99精品国语久久久| 亚洲欧美中文字幕日韩二区| 国产成人精品久久久久久| 欧美成人一区二区免费高清观看| 成人高潮视频无遮挡免费网站| 亚洲av一区综合| 天堂av国产一区二区熟女人妻| 成人国产麻豆网| 99久国产av精品| 亚洲乱码一区二区免费版| 久久精品久久久久久久性| 亚洲精品久久久久久婷婷小说 | 黄色欧美视频在线观看| 国产伦精品一区二区三区视频9| 中出人妻视频一区二区| 国产三级在线视频| 国产成人aa在线观看| 国语自产精品视频在线第100页| 日本av手机在线免费观看| 成人午夜精彩视频在线观看| 亚洲国产欧洲综合997久久,| 国产精品麻豆人妻色哟哟久久 | 观看免费一级毛片| 菩萨蛮人人尽说江南好唐韦庄 | 美女内射精品一级片tv| 麻豆成人av视频| 日本免费a在线| 国产伦在线观看视频一区| 淫秽高清视频在线观看| 亚洲丝袜综合中文字幕| 精品久久久久久久久av| 日韩大尺度精品在线看网址| 久久中文看片网| 乱码一卡2卡4卡精品| 久久久久久久久大av| 十八禁国产超污无遮挡网站| 亚洲av免费在线观看| 级片在线观看| 久久这里只有精品中国| 亚洲国产精品国产精品| 国产精品一及| 国产久久久一区二区三区| 日韩欧美一区二区三区在线观看| 亚洲不卡免费看| 国产乱人视频| 麻豆乱淫一区二区| 免费观看a级毛片全部| 极品教师在线视频| www日本黄色视频网| 校园春色视频在线观看| eeuss影院久久| 中文字幕免费在线视频6| 色综合亚洲欧美另类图片| 最近最新中文字幕大全电影3| 在线免费观看的www视频| 成人美女网站在线观看视频| 中文精品一卡2卡3卡4更新| 欧美一级a爱片免费观看看| 国产成人福利小说| 成人欧美大片| 九色成人免费人妻av| 免费一级毛片在线播放高清视频| 国产一区二区激情短视频| 看片在线看免费视频| 在线免费观看的www视频| 免费观看精品视频网站| 亚洲av免费在线观看| 免费观看精品视频网站| 久久人人爽人人爽人人片va| 联通29元200g的流量卡| 亚洲av男天堂| 十八禁国产超污无遮挡网站| 五月玫瑰六月丁香| 国产av麻豆久久久久久久| a级毛片a级免费在线| 亚洲欧美成人精品一区二区| 国产一区二区三区在线臀色熟女| 成人午夜精彩视频在线观看| 91久久精品国产一区二区三区| 亚洲无线观看免费| 69人妻影院| 国产精品一区二区在线观看99 | 天堂av国产一区二区熟女人妻| 狂野欧美激情性xxxx在线观看| 欧美日本视频| 偷拍熟女少妇极品色| 国产毛片a区久久久久| 国产精品久久久久久av不卡| 夫妻性生交免费视频一级片| 亚洲精品影视一区二区三区av| 国产精品1区2区在线观看.| 日韩欧美精品免费久久| 国产成人精品久久久久久| 一进一出抽搐动态| 免费看a级黄色片| 成熟少妇高潮喷水视频| 久久亚洲精品不卡| 精品久久久久久久久久免费视频| 床上黄色一级片| 91狼人影院| 狠狠狠狠99中文字幕| 国产精品1区2区在线观看.| 国产精华一区二区三区| 日韩一本色道免费dvd| 嘟嘟电影网在线观看| 少妇被粗大猛烈的视频| 又爽又黄a免费视频| АⅤ资源中文在线天堂| 人人妻人人看人人澡| 综合色av麻豆| 久久鲁丝午夜福利片| 一边摸一边抽搐一进一小说| 国内精品美女久久久久久| 日韩 亚洲 欧美在线| 国产精品福利在线免费观看| 成年av动漫网址| www.色视频.com| 精品久久久噜噜| 九九热线精品视视频播放| 欧美日韩国产亚洲二区| 岛国在线免费视频观看| 国产亚洲精品久久久久久毛片| 国产淫片久久久久久久久| 日日啪夜夜撸| 国产v大片淫在线免费观看| 亚洲欧洲国产日韩| 国产在线精品亚洲第一网站| a级毛片免费高清观看在线播放| 久久久久久久久久成人| 午夜福利在线观看吧|